Search

...After all appropriate and necessary treatments have been tried, breast cancer may continue to progress or worsen, and doctors may determine it’s time to stop treatment. In some cases, it...

...Hormone therapy is a treatment option for some breast cancers. Hormones like estrogen and progesterone play a role in these cancers. Thus, endocrine therapy is another name for this kind...

...Tykerb (lapatinib) is a targeted therapy used to treat advanced or metastatic breast cancer in certain people. It is used in combination with: The active ingredient in Tykerb is lapatinib...

...The term "breast cancer" refers to any cancer that begins in the breast cells. However, there is much variation between different kinds of breast cancer. These different subtypes play an...

...Nerlynx is a targeted therapy that is approved for use in early-stage breast cancer that is positive for human epidermal growth factor receptor 2 (HER2+) after treatment with trastuzumab to...

...Kadcyla is a targeted treatment used to treat some metastatic breast cancers. It is approved to treat some people with human epidermal growth factor receptor 2 positive (HER2+), metastatic breast cancer...

...Ogivri® is a targeted treatment used to treat certain people with metastatic breast cancer that is positive for the human epidermal growth factor receptor 2 (HER2+). It is used for...

...Herceptin (trastuzumab) is a targeted treatment used to treat breast cancer that is positive for the human epidermal growth factor receptor 2 (HER2+). It may be used in combination with...

...Surgery is often part of treatment for breast cancer. However, in certain cases of metastatic breast cancer, surgery on the tumor in the breast may not be recommended. There are...

...Perjeta (pertuzumab) is a targeted treatment used in combination with trastuzumab and chemotherapy for certain people with breast cancer that is positive for the human epidermal growth factor receptor 2...

...Afinitor (everolimus) is a kinase inhibitor used in combination with a drug called Aromasin (exemestane). Together, they are used to treat advanced breast cancer that is hormone receptor-positive (HR+) and...

...Lynparza (olaparib) is a targeted therapy used in certain people with metastatic breast cancer that is human epidermal growth factor receptor 2 negative (HER2-) and positive or suspected to be...

...Verzenio™ (abemaciclib) is a targeted therapy used to treat certain people with early, advanced, or metastatic breast cancer that is hormone receptor-positive and human epidermal growth factor receptor 2 (HER2)...

...Kisqali (ribociclib) is a kinase inhibitor used in combination with certain hormone therapies to treat people with certain forms of advanced or metastatic breast cancer that are hormone receptor-positive and...

...Ibrance is an oral targeted therapy. It is used to treat people with advanced or metastatic breast cancer that is hormone receptor-positive and human epidermal growth factor receptor 2 (HER2)...

...While the majority of breast cancers occur in women, breast cancer can develop in men. In 2023, an estimated 2,800 men were predicted to be diagnosed with breast cancer. Though...

...According to recent studies, a woman born today in the United States has an estimated 1 in 8 chance of developing breast cancer in her lifetime. The risk of breast...

...Breast cancer rarely occurs during pregnancy. Statistics show it occurs in about 1 out of every 3,000 pregnancies. While cancer in any form is rare during pregnancy, breast cancer is...

...While some risk factors cannot be changed (such as having a family history or known genetic mutations), there are some ways to reduce the risk of breast cancer by engaging...

...Targeted therapy is a form of precision medicine. It is a type of treatment that stops or slows cancer cell growth. Targeted therapies are considered a systemic treatment because they...